M&A Deal Summary

Syneos Health Acquires Kendle International

On July 12, 2011, Syneos Health acquired life science company Kendle International for 232M USD

Acquisition Highlights
  • This is Syneos Health’s 1st transaction in the Life Science sector.
  • This is Syneos Health’s 2nd largest (disclosed) transaction.
  • This is Syneos Health’s 1st transaction in the United States.
  • This is Syneos Health’s 1st transaction in Ohio.

M&A Deal Summary

Date 2011-07-12
Target Kendle International
Sector Life Science
Buyer(s) Syneos Health
Deal Type Going Private
Deal Value 232M USD
Advisor(s) J.P. Morgan Securities (Financial)
Keating Muething & Klekamp (Legal)

Target

Kendle International

Cincinnati, Ohio, United States
Kendle International Inc., a clinical research organization, provides Phase I-IV clinical development services on a contract basis to the biopharmaceutical industry worldwide.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Syneos Health

Morrisville, North Carolina, United States

Category Company
Founded 2010
Sector Life Science
Revenue 4.4B USD (2020)
DESCRIPTION

Syneos Health is a fully integrated biopharmaceutical solutions organization built to accelerate customer success. Syneos Health translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Syneos Health was founded in 2010 and is based in Morrisville, North Carolina.


DEAL STATS #
Overall 1 of 7
Sector (Life Science) 1 of 3
Type (Going Private) 1 of 1
State (Ohio) 1 of 1
Country (United States) 1 of 5
Year (2011) 1 of 1
Size (of disclosed) 2 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-10 inVentiv Health

Burlington, Massachusetts, United States

inVentiv Health, Inc. is a provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv offers convergent services that deliver extraordinary outcomes to clients whose goal is improving human life.

Buy $4.6B